FDA Set To Make Key Decision On Restasis Generics

Akorn, Mylan And Teva Are In The Running For ANDA Approvals

 
• By Dean Rudge
  
Yes or no decision
Restasis ANDA filers are eyeing an FDA decision by the year end • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products